Giovannoni G, et al. Cladribine tablets in high disease activity (HDA) subgroups from the CLARITY study of patients with relapsing multiple sclerosis (RMS). EP1157. EAN 2017.
Atrofie van de cortex oorzaak van versnelde achteruitgang bij progressieve MS
sep 2019 | Multipele Sclerose